@lancetrh-europe.bsky.social
The Lancet Regional Health-Europe publishes #OpenAccess research that advocates change in clinical practice & health policy in Europe.
@lancetrh-europe.bsky.socialNew study, linked to our Series "The future of maternal vaccination in Europe", shows 74% RSV vaccine effectiveness + reassuring safety profile, but uptake data suggest that the benefits may not be fully realised @edinburgh-uni.bsky.social @citystgeorges.bsky.social
Read here: shorturl.at/zZgE2
@lancetrh-europe.bsky.socialConference link: smfmglobal26.eventscribe.net/agenda.asp?p...
The series examines the evidence, policies, implementation strategies & system changes needed to improve uptake & ensure more equitable delivery across Europe.
@lancetrh-europe.bsky.socialOur Oct issue is online!
Our Editorial focuses on our new Series 'The future of maternal vaccination in Europe', chaired by
@ProfAsmaKhalil
& launching at the Society for Maternal-Fetal Medicine Global Congress on 8 October, 13:00–14:00 CEST
@lancetrh-europe.bsky.socialFully vaccinated women also had a 52% lower adjusted risk of precancerous cervical lesions.
These findings add direct evidence from Germany on the role of #HPV vaccination in cervical cancer prevention.
@lancetrh-europe.bsky.socialWhat is the real-world impact of HPV vaccination in Germany?
Using Bavarian health claims and prescription data from 669,053 women, this study found full vaccination was associated with a 65% lower adjusted risk of invasive cervical cancer.
Read more 👇
shorturl.at/Cjxcy
@lancetrh-europe.bsky.socialStephanie Becker, Senior Editor, is currently attending European Health Forum Gastein, discussing a better future for health in Europe.
Our journals are committed to supporting you on every stage of your publication journey. Learn more here: hubs.li/Q03BLcy10
@lancetrh-europe.bsky.socialPublic health and social policies must address adversity more broadly, considering the interplay between individual vulnerability, family adversity, and the structural conditions of the communities in which children grow up. #ChildhoodAdversity #PublicHealth #HealthInequalities
@lancetrh-europe.bsky.socialNew study of 1.24M people shows childhood adversity is multilayered: individual, family, and neighbourhood adversities can amplify one another. High family + individual adversity was linked to 7.16 × higher mortality risk in young adulthood. shorturl.at/EPBU0
@lancetrh-europe.bsky.socialHow can advances in #HCC care reach more patients across Europe?
The Series highlights the need for coordinated approaches across prevention, surveillance, treatment, reimbursement, and policy to reduce disparities and improve outcomes.
@lancetrh-europe.bsky.social@lancetrh-europe.bsky.socialThe landscape of hepatocellular carcinoma in Europe is changing.
Chaired by Prof David Pinato, the Series examines the evolving #HCC burden, persistent surveillance gaps, advances in treatment and inequalities in access to care.
Read more 👇
shorturl.at/qo8g1
@lancetrh-europe.bsky.socialConversation-level, real-world evaluation with clinical expert adjudication should be treated as a design requirement for patient-facing medical #LLMs.
@uni-wuerzburg.de
@lancetrh-europe.bsky.socialAre medical chatbots safe?
New study analysed conversations with a #ParkinsonsDisease chatbot. #AI triage classified 89% as good, but clinical review found critical errors—eg, inappropriate medication advice and inadequate response to suicidal ideation
@lancetrh-europe.bsky.social🆕 analysis of GBD 2023 data finds that brain disorders caused over a quarter of Norway’s total health burden in 2023.
Dementia, anxiety, stroke, headache and depression were the leading contributors.
@lancetrh-europe.bsky.social#Incretin-based therapies have transformed #obesity treatment, but health systems have not kept pace
New @easoobesity.bsky.social position statement defines this paradox and proposes a model for integrating incretin-based therapies into comprehensive #ObesityCare
@lancetrh-europe.bsky.socialOur Sep issue is live!
The editorial focuses on Ménière’s disease, which causes unpredictable vertigo, tinnitus & progressive hearing loss.
Yet despite widespread use of surgical treatments, evidence for their treatment-specific efficacy remains limited.
@lancetrh-europe.bsky.socialSeparating doses could delay protection, increase missed appointments, and reduce coverage, with far reaching consequences for #VaccineHesitancy even in Europe.
Vaccine decisions must remain anchored in science, with transparent communication to sustain #VaccineConfidence
@lancetrh-europe.bsky.socialThe US has moved to reduce routine #ChildhoodVaccinations and replace the combined #MMR vaccine with separate vaccines.
Marco Cavaleri highlights that there is no evidence single-antigen vaccines offer greater safety or effectiveness
@ema.europa.eu
@lancetrh-europe.bsky.social🎧 New podcast episode
How can families be supported during war and displacement?
Sydney Tucker (@sydtuck.bsky.social), Susan Hillis, and Tetiana Machabeli discuss Hope Groups in Ukraine, a community-based intervention for caregivers and children.
Listen now 👇
shorturl.at/nHKla
@lancetrh-europe.bsky.socialWe discussed whether wider access to GLP-1 therapies could help reduce inequalities, while recognising the limited evidence in many underserved populations. & while AI, digital health & devices advance rapidly, equitable blood pressure detection & control remain basic priorities
